发明名称 TUMOUR NECROSIS FACTOR ALPHA CONVERTASE
摘要 The present invention relates to tumor necrosis factor alpha (TNF.alpha.), and more specifically to the enzyme TNF.alpha.-convertase (TNF.alpha.-con) that can proteolytically convert TNF.alpha. precursor to mature TNF.alpha.. The present invention provides DNA sequences encoding mammalian TNF.alpha.-con and functional equivalents thereof, recombinant expression vectors comprising said DNA sequences, host cell lines comprising said expression vectors, inhibitors of TNF.alpha.-con, inhibitors modified for use as ligands for affinity purification of TNF.alpha.-con, and methods for treating diseases or conditions resulting from abnormal levels of TNF.alpha. in a mammalian subject.
申请公布号 CA2249985(A1) 申请公布日期 1997.10.02
申请号 CA19972249985 申请日期 1997.03.25
申请人 GLAXO GROUP LIMITED 发明人 ROCQUE, WARREN J.;MCGEEHAN, GERARD M.;DIDSBURY, JOHN R.;JIN, SHIOW-LIAN CATHERINE;CHEN, WEN-JI;MOSS, MARCIA L.;BECHERER, JAMES DAVID;SCHOENEN, FRANK J.
分类号 C12N15/09;A61K31/00;A61K45/00;A61P1/00;A61P3/00;A61P3/10;A61P9/00;A61P9/10;A61P15/00;A61P17/00;A61P17/06;A61P19/00;A61P19/10;A61P25/00;A61P29/00;A61P31/00;A61P31/02;A61P31/18;A61P33/00;A61P33/06;A61P37/00;A61P37/06;A61P37/08;A61P43/00;C07C323/60;C07D513/04;C07K19/00;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N9/64;C12Q1/37;(IPC1-7):C12N15/57;C07H21/00;A61K48/00;A61K31/16;A61K38/48;A61K31/70;C12N9/96 主分类号 C12N15/09
代理机构 代理人
主权项
地址